OPA-15406 not checked

Otsuka

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
2 active
9 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Atopic Dermatitis (AD) (2 trials)
Main trialPhase 3
“To investigate the superiority of 1% OPA-15406 foam to the vehicle in adult patients with atopic dermatitis (AD).”In the company’s words, NCT07173478 on ClinicalTrials.gov
Other names
difamilast

Other drugs for Atopic Dermatitis (AD)

All 90 drugs for Atopic Dermatitis (AD)

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials9

TrialPhaseCompletesWhat it tests
Phase 3Not yet recruiting Dec 2026 A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic Dermatitis
Phase 3Not yet recruiting Feb 2027 A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis
Phase 3Completed 13 Dec 2019 Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis
Phase 3Completed 28 Dec 2019 Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome
Phase 3Completed 11 Nov 2020 Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis
Phase 3Completed 29 Dec 2022 A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis
Phase 3Completed 17 Jun 2024 To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD
Phase 3Completed 21 Jul 2024 To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients with AD
Phase 2Completed 28 Jan 2015 A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow OPA-15406

Following is part of Solo: you see every change to OPA-15406 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in